BRCA2 and a few other genes increase risk of aggressive prostate cancer.
Hereditary contribution to prostate cancer is recognized.
BRCA2, BRCA1, HOXB13, ATM, MMR genes.
Hereditary cancer panel including BRCA.
Metastatic disease, young onset, family history.
Screening and treatment selection.
Contact Gene Negar Ayandegan for sample submission, laboratory collaboration, or more information.
BRCA1 and BRCA2 Testing at Gene Negar Ayandegan
BRCA1 and BRCA2 gene testing to assess inherited risk of breast, ovarian, prostate and pancreatic cancer.
Hereditary Cancer Panel at Gene Negar Ayandegan
Hereditary cancer gene panel to assess inherited risk of familial cancers and cancer predisposition syndromes.
NGS Cancer Panel at Gene Negar Ayandegan
Targeted NGS panels analyzing somatic variants to guide targeted therapy in solid tumors and hematologic malignancies.
Gene Negar Ayandegan · Hereditary Prostate Cancer